Skip to Content
Global News Select

Biogen Down Over 7%, Worst Performer in the S&P 500 and Nasdaq 100 So Far Today — Data Talk

Biogen Inc. (BIIB) is currently at $297.78, down $23.77 or 7.39%

 

-- Would be lowest close since June 4, 2021, when it closed at $286.14

-- On pace for largest percent decrease since Nov. 9, 2020, when it fell 28.17%

-- Currently down seven consecutive days; down 13.54% over this period

-- Longest losing streak since Dec. 24, 2018, when it fell for eight straight trading days

-- Worst seven day stretch since the seven days ending Nov. 17, 2020, when it fell 24.35%

-- Down 12.14% month-to-date

-- Up 21.61% year-to-date

-- Down 32.08% from its all-time closing high of $438.43 on March 20, 2015

-- Up 11.73% from 52 weeks ago (Sept. 10, 2020), when it closed at $266.51

-- Down 28.2% from its 52 week closing high of $414.71 on June 10, 2021

-- Up 26.04% from its 52 week closing low of $236.26 on Nov. 9, 2020

-- Traded as low as $297.52; lowest intraday level since June 7, 2021, when it hit $286.00

-- Down 7.47% at today's intraday low; largest intraday percent decrease since July 15, 2021, when it fell as much as 8.05%

-- Worst performer in the S&P 500 today

-- Worst performer in the Nasdaq 100 today

 

All data as of 11:36:55 AM ET

 

Source: Dow Jones Market Data, FactSet

 

(END) Dow Jones Newswires

September 09, 2021 11:56 ET (15:56 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.